• FirefoxInstall the new Firefox »
  •  Dow Up0.86% Nasdaq Up0.90%

    Spectrum Pharmaceuticals, Inc. (SPPI)

    -NasdaqGS
    6.16 Down 0.07(1.12%) Mar 2, 4:00PM EST
    |After Hours : 6.16 0.00 (0.00%) Mar 2, 5:09PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 155,854   267,707   192,963  
    Cost of Revenue28,580  46,633  33,838  
    Gross Profit 127,274   221,074   159,125  
    Operating Expenses
    Research Development46,670  41,560  26,662  
    Selling General and Administrative99,315  89,922  72,197  
    Non Recurring -   -   -  
    Others20,074  8,818  3,720  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (38,785) 80,774   56,546  
    Income from Continuing Operations
    Total Other Income/Expenses Net4,341  (359)(3,208)
    Earnings Before Interest And Taxes(36,636)79,930  53,635  
    Interest Expense -   -   -  
    Income Before Tax(36,636)79,930  53,635  
    Income Tax Expense25,498  (14,271)3,704  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(62,134)94,201  49,931  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (62,134) 94,201   49,931  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (62,134) 94,201   49,931  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.